Detalhe da pesquisa
1.
SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma.
Mod Pathol
; 31(9): 1442-1456, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29700418
2.
Molecular Characterization of Neuroendocrine Carcinomas of the Endometrium: Representation in All 4 TCGA Groups.
Am J Surg Pathol
; 44(11): 1541-1548, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32773531
3.
Alisertib plus induction chemotherapy in previously untreated patients with high-risk, acute myeloid leukaemia: a single-arm, phase 2 trial.
Lancet Haematol
; 7(2): e122-e133, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31837959
4.
Gene expression profiling distinguishes prefibrotic from overtly fibrotic myeloproliferative neoplasms and identifies disease subsets with distinct inflammatory signatures.
PLoS One
; 14(5): e0216810, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31071164
5.
Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.
J Clin Oncol
; 37(22): 1868-1875, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30939096
6.
Randomized trial of 10 days of decitabine ± bortezomib in untreated older patients with AML: CALGB 11002 (Alliance).
Blood Adv
; 2(24): 3608-3617, 2018 12 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-30567725